Director of Denali Therapeutics Inc. (NASDAQ:DNLI), Schenkein David P, sells 25,000 shares worth $2,251,555
According to Denali Therapeutics Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 23 09:52 PM, company Director, Schenkein David P disclosed selling 25,000 shares at a cost of $90.06. At the time of this transaction (Dec 21), this trade was worth $2,251,555 in total. As of Dec 21, Schenkein David P now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Denali Therapeutics Inc. (NASDAQ:DNLI) Director, Schenkein David P, we have the following information:
SEC Form 4 filing: Dec 21: Sold 5,000 shares at the rate of $90.01 per share. Total worth of this trade was $450,027. Total number of shares owned as of Dec 21 were 26,232
Director of Denali Therapeutics Inc. (NASDAQ:DNLI), Schenkein David P, sells 5,000 shares worth $450,027
According to Denali Therapeutics Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 23 09:52 PM, company Director, Schenkein David P disclosed selling 5,000 shares at a cost of $90.01. At the time of this transaction (Dec 21), this trade was worth $450,027 in total. As of Dec 21, Schenkein David P now owns 26,232 shares in total worth about $2,310,252.2399999998.
For the last few recent trades made by Denali Therapeutics Inc. (NASDAQ:DNLI) Director, Schenkein David P, we have the following information:
SEC Form 4 filing: Dec 21: Sold 25,000 shares at the rate of $90.06 per share. Total worth of this trade was $2,251,555. Total number of shares owned as of Dec 21 were 0